Cladrim Cladribine 10 Mg Injection

Description

Introduction Of Cladrim 10mg/10ml Injection:

Cladribine is a synthetic purine analog, meaning it is a man-made compound similar in structure to purine, a component of DNA and RNA. It was initially developed as an anticancer drug due to its ability to interfere with the growth and proliferation of cancer cells. However, it has also found application in the treatment of multiple sclerosis, specifically relapsing forms.

Mechanism Of Action Of Cladrim 10mg/10ml Injection:

Cladribine is a prodrug, which means it requires activation within the body to become active. Once inside the body, it is converted into an active form, cladribine triphosphate. This active form interferes with DNA synthesis and repair, disrupting the replication and function of lymphocytes, particularly B and T lymphocytes. By inhibiting the DNA synthesis, cladribine induces apoptosis (cell death) in these lymphocytes, leading to a reduction in their numbers and activity.

Uses Of Cladrim 10mg/10ml Injection:

Multiple Sclerosis (MS): Cladribine is primarily used for the treatment of relapsing forms of multiple sclerosis (RMS), including relapsing-remitting MS (RRMS) and active secondary progressive MS (SPMS). It helps reduce the frequency of relapses and delay the progression of disability associated with MS.

Benefits Of Cladrim 10mg/10ml Injection:

1. High Efficacy: Clinical trials have shown that cladribine is highly effective in reducing the annualized relapse rate and slowing down the progression of disability in individuals with MS.
2. Convenience of Administration: Cladribine is typically administered orally in a few short courses over a two-year period, offering convenience compared to other disease-modifying therapies that often require regular injections or infusions.
3. Durable Effectiveness: Cladribine treatment involves short periods of dosing, and its effects can last for an extended period, reducing the need for frequent administration.

Contact Us